GlassScriptPhysician profile
Simon Chivi
NPI 1306307228
$1,916.34
in general payments reported to CMS, 2019-2025
11 companies · $1,799 in 2025
The $1,799 reported for 2025 was more than what 89% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $117 · 2025: $1,799.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,844.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,843.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $500.30 | 2025 | Indigo System |
| Trisalus Life Sciences, INC. | $301.94 | 2025 | Trinav Infusion System |
| Argon Medical Devices, INC. | $234.70 | 2025 | Clot Management |
| Boston Scientific Corporation | $227.84 | 2025 | Therasphere Y90 Glass Microspheres 10 Gbq, Angiojet Ultra 5000a |
| Sirtex Medical INC | $145.29 | 2025 | Sir-Spheres Microspheres |
| C. R. Bard, INC. & Subsidiaries | $121.00 | 2025 | Wavelinq, Lutonix Drug Coated Balloon |
| Stryker Corporation | $114.07 | 2025 | Artix Mt, Inthrill Thrombectomy Catheter, Flowtriever |
| Bard Peripheral Vascular, INC. | $92.24 | 2025 | Covera |
| Astrazeneca Pharmaceuticals LP | $44.68 | 2024 | Imfinzi |
| W. L. Gore & Associates, INC. | $41.57 | 2025 | Gore Viatorr Tips Endoprosthesis With Controlled Expansion |
| Imperative Care, INC | $19.90 | 2025 | Zoom 7x Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Simon Chivi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.